Advertisement

American Journal of Clinical Dermatology

, Volume 15, Issue 6, pp 525–536 | Cite as

Complications of Decorative Tattoos: Recognition and Management

  • Carolina Simunovic
  • Michi M. ShinoharaEmail author
Review Article

Abstract

Tattooing is an ancient practice that enjoys continued popularity. Although a modern, professionally performed tattoo is generally safe, complications can occur. A skin biopsy of all tattoo reactions is recommended as some tattoo reactions have systemic implications. Tattoo-related infections are seen days to decades after tattooing, and range from acute pyogenic infections to cutaneous tuberculosis. In particular, non-tuberculous mycobacterial infections happen in tattoos with increasing frequency and are introduced at the time of tattooing through contaminated ink or water used to dilute inks. Despite a transition in tattoo pigments from metal salts to industrial azo dyes, hypersensitivity reactions also persist, and include eczematous, granulomatous, lichenoid, and pseudoepitheliomatous patterns (among others). Granulomatous tattoo reactions can be a clue to cutaneous or systemic sarcoidosis, particularly in the setting of interferon use. Pseudoepitheliomatous tattoo reactions have substantial overlap with squamous cell carcinoma and keratoacanthoma, making diagnosis and management difficult. Other malignancies and their benign mimics can occur in tattoos, raising questions about the safety of tattoo ink and its role in carcinogenesis.

Keywords

Sarcoidosis Pyoderma Gangrenosum Verrucous Carcinoma Sarcoidal Granuloma Cutaneous Sarcoidosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

Carolina Simunovic, MD, and Michi Shinohara, MD, thank Drs. David Friedman, Stanley Hurst, Roy Colven, and John Olerud for providing clinical photos. Carolina Simunovic and Michi Shinohara report no conflicts of interest or sources of funding.

References

  1. 1.
    Kean WF, Tocchio S, Kean M, Rainsford KD. The musculoskeletal abnormalities of the Similaun Iceman (‘ÖTZI’): clues to chronic pain and possible treatments. Inflammopharmacology. 2013;21(1):11–20.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Harris Interactive: Harris Polls > One in Five US Adults Now Has a Tattoo. (Online). http://www.harrisinteractive.com/NewsRoom/HarrisPolls/tabid/447/mid/1508/articleId/970/ctl/ReadCustom%20Default/Default.aspx. Accessed 03 Sept 2014.
  3. 3.
    Kazandjieva J, Tsankov N. Tattoos: dermatological complications. Clin Dermatol. 2007;25(4):375–82.PubMedCrossRefGoogle Scholar
  4. 4.
    Sperry K. Tattoos and tattooing. Part I: history and methodology. Am J Forensic Med Pathol. 1991;12(4):313–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Hellard ME, Aitken CK, Hocking JS. Tattooing in prisons–not such a pretty picture. Am J Infect Control. 2007;35(7):477–80.PubMedCrossRefGoogle Scholar
  6. 6.
    FDA Office of the Commissioner, “Consumer Updates—Think Before You Ink: Are Tattoos Safe?,” Oct-2009. (Online). http://www.fda.gov/forconsumers/consumerupdates/ucm048919.htm. Accessed 24 Aug 2014.
  7. 7.
    Engel E, Vasold R, Santarelli F, Maisch T, Gopee NV, Howard PC, Landthaler M, Bäumler W. Tattooing of skin results in transportation and light-induced decomposition of tattoo pigments—a first quantification in vivo using a mouse model. Exp Dermatol. 2010;19(1):54–60.PubMedCrossRefGoogle Scholar
  8. 8.
    Regensburger J, Lehner K, Maisch T, Vasold R, Santarelli F, Engel E, Gollmer A, König B, Landthaler M, Bäumler W. Tattoo inks contain polycyclic aromatic hydrocarbons that additionally generate deleterious singlet oxygen. Exp Dermatol. 2010;19(8):e275–81.PubMedCrossRefGoogle Scholar
  9. 9.
    Høgsberg T, Jacobsen NR, Clausen PA, Serup J. Black tattoo inks induce reactive oxygen species production correlating with aggregation of pigment nanoparticles and product brand but not with the polycyclic aromatic hydrocarbon content. Exp Dermatol. 2013;22(7):464–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Møller P, Wallin H. Genotoxic hazards of azo pigments and other colorants related to 1-phenylazo-2-hydroxynaphthalene. Mutat Res. 2000;462(1):13–30.PubMedCrossRefGoogle Scholar
  11. 11.
    Starbrite Tattoo Ink MSDS Sheets. (Online). http://www.superiortattoo.com/MSDS/Starbrite.html. Accessed 24 Aug 2014.
  12. 12.
    Intenze Tattoo Ink MSDS Sheets|Intenze Tattoo Ink. (Online). http://www.intenzetattooink.com/intenze-tattoo-ink-university/intenze-tattoo-ink-msds-sheets. Accessed 24 Aug 2014.
  13. 13.
    MSDS/Downloads. (Online). http://www.eternaltattoosupply.com/MSDSDownloads_ep_43-1.html. Accessed 24 Aug 2014.
  14. 14.
    O. of the Commissioner, “Safety Alerts for Human Medical Products—White and Blue Lion Tattoo Kits: Recall—Bacterial Contamination of Needles and Ink Bottles.” (Online). http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm408902.htm. Accessed 03 Sept 2014.
  15. 15.
    LeBlanc PM, Hollinger KA, Klontz KC. Tattoo ink-related infections—awareness, diagnosis, reporting, and prevention. N Engl J Med. 2012;367(11):985–7.PubMedCrossRefGoogle Scholar
  16. 16.
    FAQs on Tattoo Inks—BfR. (Online). http://www.bfr.bund.de/en/faqs_on_tattoo_inks-187895.html#topic_187899. Accessed: 21 Aug 2014.
  17. 17.
    De Cuyper C. Permanent makeup: indications and complications. Clin Dermatol. 2008;26(1):30–4.PubMedCrossRefGoogle Scholar
  18. 18.
    Ortiz AE, Alster TS. Rising concern over cosmetic tattoos Dermatol Surg Off Publ Am Soc Dermatol Surg Al 2012;38(3):424–9.Google Scholar
  19. 19.
    Vassileva S, Hristakieva E. Medical applications of tattooing. Clin Dermatol. 2007;25(4):367–74.PubMedCrossRefGoogle Scholar
  20. 20.
    Kluger N. Acute complications of tattooing presenting in the ED. Am J Emerg Med. 2012;30(9):2055–63.PubMedCrossRefGoogle Scholar
  21. 21.
    Centers for Disease Control and Prevention (CDC). Methicillin-resistant Staphylococcus aureus skin infections among tattoo recipients—Ohio, Kentucky, and Vermont, 2004–2005. MMWR Morb Mortal Wkly Rep. 2006;55(24):677–9.Google Scholar
  22. 22.
    Wallace RJ, Brown BA, Griffith DE. Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol. 1998;52:453–90.PubMedCrossRefGoogle Scholar
  23. 23.
    Centers for Disease Control and Prevention (CDC). Tattoo-associated nontuberculous mycobacterial skin infections–multiple states, 2011–2012. MMWR Morb Mortal Wkly Rep. 2012;61(33):653–6.Google Scholar
  24. 24.
    Philips RC, Hunter-Ellul LA, Martin JE, Wilkerson MG. Mycobacterium fortuitum infection arising in a new tattoo. Dermatol Online J 2014;20(6). http://www.escholarship.org/uc/item/6bs3q0h0.
  25. 25.
    Kennedy BS, Bedard B, Younge M, Tuttle D, Ammerman E, Ricci J, Doniger AS, Escuyer VE, Mitchell K, Noble-Wang JA, O’Connell HA, Lanier WA, Katz LM, Betts RF, Mercurio MG, Scott GA, Lewis MA, Goldgeier MH. Outbreak of Mycobacterium chelonae infection associated with tattoo ink. N Engl J Med. 2012;367(11):1020–4.PubMedCrossRefGoogle Scholar
  26. 26.
    Falsey RR, Kinzer MH, Hurst S, Kalus A, Pottinger PS, Duchin JS, Zhang J, Noble-Wang J, Shinohara MM. Cutaneous inoculation of nontuberculous mycobacteria during professional tattooing: a case series and epidemiologic study. Clin Infect Dis Off Publ Infect Dis Soc Am. 2013;57(6):e143–7.CrossRefGoogle Scholar
  27. 27.
    Drage LA, Ecker PM, Orenstein R, Phillips PK, Edson RS. An outbreak of Mycobacterium chelonae infections in tattoos. J Am Acad Dermatol. 2010;62(3):501–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Wong H-W, Tay Y-K, Sim C-S. Papular eruption on a tattoo: a case of primary inoculation tuberculosis. Australas J Dermatol. 2005;46(2):84–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Ghorpade A. Inoculation (tattoo) leprosy: a report of 31 cases. J Eur Acad Dermatol Venereol JEADV. 2002;16(5):494–9.CrossRefGoogle Scholar
  30. 30.
    Barker FR. Notes of cases on an outbreak of syphilis following on tattooing. Br Med J. 1889;1(1479):985–9.PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Long GE, Rickman LS. Infectious complications of tattoos. Clin Infect Dis Off Publ Infect Dis Soc Am. 1994;18(4):610–9.CrossRefGoogle Scholar
  32. 32.
    Yuan J, Li W, Xia Z, Shan S-J, Guo Y, Chen H-D. Secondary syphilis presenting in a red tattoo. Eur J Dermatol EJD. 2010;20(4):544–5.Google Scholar
  33. 33.
    Parker C, Kaminski G, Hill D. Zygomycosis in a tattoo, caused by Saksenaea vasiformis. Australas J Dermatol. 1986;27(3):107–11.PubMedCrossRefGoogle Scholar
  34. 34.
    Kluger N, Saarinen K. Aspergillus fumigatus infection on a home-made tattoo. Br J Dermatol. 2014;170(6):1373–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Ammirati CT. What is your diagnosis? Tinea in tattoo. Cutis. 2004;73(4):228–32.Google Scholar
  36. 36.
    Ishizaki S, Sawada M, Suzaki R, Kobayashi K, Ninomiya J, Tanaka M, Harada T, Kawana S, Uchida H. Tinea faciei by Microsporum gypseum mimicking allergic reaction following cosmetic tattooing of the eyebrows. Med Mycol J. 2012;53(4):263–6.PubMedCrossRefGoogle Scholar
  37. 37.
    López-Medrano F, Costa JR, Rodriguez-Peralto JL, Aguado JM. An HIV-positive man with tattoo induration. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;45(2):220–221, 267–268.Google Scholar
  38. 38.
    Colebunders R, Depraetere K, Verstraeten T, Lambert J, Hauben E, Van Marck E, Maurer T, Bañuls AL, Dujardin JC. Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection. J Am Acad Dermatol. 1999;41(5 Pt 2):847–50.PubMedCrossRefGoogle Scholar
  39. 39.
    de Nishioka SA, Gyorkos TW. Tattoos as risk factors for transfusion-transmitted diseases. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2001;5(1):27–34.Google Scholar
  40. 40.
    Doll DC. Tattooing in prison and HIV infection. Lancet. 1988;1(8575–6):66–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Carney K, Dhalla S, Aytaman A, Tenner CT, Francois F. Association of tattooing and hepatitis C virus infection: a multicenter case-control study. Hepatol Baltim MD. 2013;57(6):2117–23.CrossRefGoogle Scholar
  42. 42.
    Tohme RA, Holmberg SD. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;54(8):1167–78.CrossRefGoogle Scholar
  43. 43.
    Marshall CS, Murphy F, McCarthy SE, Cheng AC. Herpes compunctorum: cutaneous herpes simplex virus infection complicating tattooing. Med J Aust. 2007;187(10):598.PubMedGoogle Scholar
  44. 44.
    Baxter SY, Deck DH. Tattoo-acquired verruca plana. Am Fam Physician. 1993;47(4):732.PubMedGoogle Scholar
  45. 45.
    Miller DM, Brodell RT. Verruca restricted to the areas of black dye within a tattoo. Arch Dermatol. 1994;130(11):1453–4.PubMedCrossRefGoogle Scholar
  46. 46.
    Ragland HP, Hubbell C, Stewart KR, Nesbitt LT. Verruca vulgaris inoculated during tattoo placement. Int. J. Dermatol. 1994;33(11):796–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Sáez M, Rodríguez-Martín M, Sidro-Sarto M, de Cabrera Paz R, Rodríguez-García F, Fagundo-González E, Carnerero A, Guimerá F, García-Bustínduy M, Sánchez R, Martín Herrera A, Noda A. Multiple verrucae vulgaris in a young woman’s tattoo. J Eur Acad Dermatol Venereol JEADV. 2006;20(3):356–7.CrossRefGoogle Scholar
  48. 48.
    Wanat KA, Tyring S, Rady P, Kovarik CL. Human papillomavirus type 27 associated with multiple verruca within a tattoo: report of a case and review of the literature. Int J Dermatol. 2014;53(7):882–4.PubMedCrossRefGoogle Scholar
  49. 49.
    Brajac I, Loncarek K, Stojnić-Sosa L, Gruber F. Delayed onset of warts over tattoo mark provoked by sunburn. J Eur Acad Dermatol Venereol JEADV. 2005;19(2):247–8.CrossRefGoogle Scholar
  50. 50.
    De Giorgi V, Grazzini M, Lotti T. A three-dimensional tattoo: Molluscum contagiosum. Can Med Assoc J. 2010;182(9):E382.Google Scholar
  51. 51.
    Molina L, Romiti R. Molluscum contagiosum on tattoo. An Bras Dermatol. 2011;86(2):352–4.PubMedCrossRefGoogle Scholar
  52. 52.
    Ruiz-Villaverde R, Sánchez-Cano D. Pearled papules over tattoo: molluscum cotagiosum. Pan Afr Med J. 2013;16:49.PubMedCentralPubMedCrossRefGoogle Scholar
  53. 53.
    Kluger N. Cutaneous complications related to permanent decorative tattooing. Expert Rev Clin Immunol. 2010;6(3):363–71.PubMedCrossRefGoogle Scholar
  54. 54.
    Kluger N, Godenèche J, Vermeulen C. Granuloma annulare within the red dye of a tattoo. J Dermatol. 2012;39(2):191–3.PubMedCrossRefGoogle Scholar
  55. 55.
    Bagwan IN, Walker M, Theaker JM. Granuloma annulare-like tattoo reaction. J Cutan Pathol. 2007;34(10):804–5.PubMedCrossRefGoogle Scholar
  56. 56.
    Wood A, Hamilton SA, Wallace WA, Biswas A. Necrobiotic granulomatous tattoo reaction: report of an unusual case showing features of both necrobiosis lipoidica and granuloma annulare patterns. Am J Dermatopathol. 2014;36(8):e152–5.PubMedCrossRefGoogle Scholar
  57. 57.
    Rubianes EI, Sánchez JL. Granulomatous dermatitis to iron oxide after permanent pigmentation of the eyebrows. J Dermatol Surg Oncol. 1993;19(1):14–6.PubMedCrossRefGoogle Scholar
  58. 58.
    Eun HC, Kim KH. Allergic granuloma from cosmetic eyebrow tattooing. Contact Dermat. 1989;21(4):276–8.CrossRefGoogle Scholar
  59. 59.
    Ito T, Fujita Y, Nishie W, Hirata Y, Shimizu H. Spontaneously resolving granulomatous tattoo reaction in multiple color regions. J Dermatol. 2014;41(7):647–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Jones B, Oh C, Egan CA. Spontaneous resolution of a delayed granulomatous reaction to cosmetic tattoo. Int J Dermatol. 2008;47(1):59–60.PubMedCrossRefGoogle Scholar
  61. 61.
    Kluger N. Sarcoidosis on tattoos: a review of the literature from 1939 to 2011. Sarcoidosis Vasc Diffus Lung Dis Off J WASOG World Assoc Sarcoidosis Granulomatous Disord. 2013;30(2):86–102.Google Scholar
  62. 62.
    Judson MA. The diagnosis of sarcoidosis. Clin Chest Med. 2008;29(3):415–427.Google Scholar
  63. 63.
    Marchell RM, Judson MA. Cutaneous sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):442–51.PubMedCrossRefGoogle Scholar
  64. 64.
    Haimovic A, Sanchez M, Judson MA, Prystowsky S. Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. J Am Acad Dermatol. 2012;66(5):699.e1–18. (quiz 717–718).Google Scholar
  65. 65.
    Ball NJ, Kho GT, Martinka M. The histologic spectrum of cutaneous sarcoidosis: a study of twenty-eight cases. J Cutan Pathol. 2004;31(2):160–8.PubMedCrossRefGoogle Scholar
  66. 66.
    Werchniak AE, Cheng SX, Dhar AD, Klaus SN. Sarcoidosis presenting as tattoo changes in a patient undergoing treatment with interferon-alpha and ribavirin. Clin Exp Dermatol. 2004;29(5):547–8.PubMedCrossRefGoogle Scholar
  67. 67.
    Chakravarty SD, Harris ME, Schreiner AM, Crow MK. Sarcoidosis triggered by interferon-beta treatment of multiple sclerosis: a case report and focused literature review. Semin Arthritis Rheum. 2012;42(2):206–12.PubMedCrossRefGoogle Scholar
  68. 68.
    Nawras A, Alsolaiman MM, Mehboob S, Bartholomew C, Maliakkal B. Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature. Dig Dis Sci. 2002;47(7):1627–31.PubMedCrossRefGoogle Scholar
  69. 69.
    Atluri D, Iduru S, Veluru C, Mullen K. A levitating tattoo in a hepatitis C patient on treatment. Liver Int Off J Int Assoc Study Liver. 2010;30(4):583–4.CrossRefGoogle Scholar
  70. 70.
    Martins EV, Gaburri AK, Gaburri D, Sementilli A. Cutaneous sarcoidosis: an uncommon side effect of pegylated interferon and ribavirin use for chronic hepatitis C. Case Rep Gastroenterol. 2009;3(3):366–71.PubMedCentralPubMedCrossRefGoogle Scholar
  71. 71.
    Toulemonde A, Quereux G, Dréno B. Sarcoidosis granuloma on a tattoo induced by interferon alpha. Ann Dermatol Vénéréologie. 2004;131(1 Pt 1):49–51.CrossRefGoogle Scholar
  72. 72.
    Körner R, Pföhler C, Vogt T, Müller CSL. Histopathology of body art revisited—analysis and discussion of 19 cases. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2013;11(11):1073–80.Google Scholar
  73. 73.
    Hurst EA, Mauro T. Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature. Arch Dermatol. 2005;141(7):865–8.PubMedCrossRefGoogle Scholar
  74. 74.
    Thum CK, Biswas A. Inflammatory complications related to tattooing: a histopathological approach based on pattern analysis. Am J Dermatopathol. 2013 [Epub ahead of print].Google Scholar
  75. 75.
    Shinohara MM, Nguyen J, Gardner J, Rosenbach M, Elenitsas R. The histopathologic spectrum of decorative tattoo complications. J Cutan Pathol. 2012;39(12):1110–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Marchesi A, Parodi PC, Brioschi M, Marchesi M, Bruni B, Cangi MG, Vaienti L. Tattoo ink-related cutaneous pseudolymphoma: a rare but significant complication. Case report and review of the literature. Aesthet Plast Surg. 2014;38(2):471–8.CrossRefGoogle Scholar
  77. 77.
    Cristaudo A, Forte G, Bocca B, Petrucci F, Muscardin L, Trento E, Di Carlo A. Permanent tattoos: evidence of pseudolymphoma in three patients and metal composition of the dyes. Eur J Dermatol EJD. 2012;22(6):776–80.Google Scholar
  78. 78.
    Campolmi P, Bassi A, Bonan P, Cannarozzo G, Gola M, Rossi Degl’Innocenti D, Lottic T, Massi D. Cutaneous pseudolymphoma localized to black tattoo. J Am Acad Dermatol. 2011;65(5):e155–7.Google Scholar
  79. 79.
    Gutermuth J, Hein R, Fend F, Ring J, Jakob T. Cutaneous pseudolymphoma arising after tattoo placement. J Eur Acad Dermatol Venereol JEADV. 2007;21(4):566–7.Google Scholar
  80. 80.
    Kahofer P, El Shabrawi-Caelen L, Horn M, Kern T, Smolle J. Pseudolymphoma occurring in a tattoo. Eur J Dermatol EJD. 2003;13(2):209–12.Google Scholar
  81. 81.
    Kluger N, Vermeulen C, Moguelet P, Cotten H, Koeb MH, Balme B, Fusade T. Cutaneous lymphoid hyperplasia (pseudolymphoma) in tattoos: a case series of seven patients. J Eur Acad Dermatol Venereol JEADV. 2010;24(2):208–13.CrossRefGoogle Scholar
  82. 82.
    Moulonguet I, Garçon N, Rivet J, Cavelier-Balloy B. Nodule developing over a tattoo: challenge. Cutaneous lymphoid hyperplasia (pseudolymphoma). Am J Dermatopathol. 2014;36(1):88–9, 101–2.Google Scholar
  83. 83.
    Hussein MRA. Cutaneous pseudolymphomas: inflammatory reactive proliferations. Expert Rev Hematol. 2013;6(6):713–33.PubMedCrossRefGoogle Scholar
  84. 84.
    Sangueza OP, Yadav S, White CR, Braziel RM. Evolution of B-cell lymphoma from pseudolymphoma. A multidisciplinary approach using histology, immunohistochemistry, and Southern blot analysis. Am J Dermatopathol. 1992;14(5):408–13.PubMedCrossRefGoogle Scholar
  85. 85.
    Patrizi A, Raone B, Savoia F, Bacci F, Pileri A, Gurioli C, Neri I. Tattoo-associated pseudolymphomatous reaction and its successful treatment with hydroxychloroquine. Acta Derm Venereol. 2009;89(3):327–8.PubMedCrossRefGoogle Scholar
  86. 86.
    Antony FC, Harland CC. Red ink tattoo reactions: successful treatment with the Q-switched 532 nm Nd:YAG laser. Br J Dermatol. 2003;149(1):94–8.PubMedCrossRefGoogle Scholar
  87. 87.
    Garcovich S, Carbone T, Avitabile S, Nasorri F, Fucci N, Cavani A. Lichenoid red tattoo reaction: histological and immunological perspectives. Eur J Dermatol EJD. 2012;22(1):93–6.Google Scholar
  88. 88.
    Mortimer NJ, Chave TA, Johnston GA. Red tattoo reactions. Clin Exp Dermatol. 2003;28(5):508–10.PubMedCrossRefGoogle Scholar
  89. 89.
    Jacks SK, Zirwas MJ, Mosser JL. A case of a generalized lichenoid tattoo reaction. J Clin Aesthet Dermatol. 2014;7(8):48–50.PubMedCentralPubMedGoogle Scholar
  90. 90.
    Serup J, Hutton Carlsen K. Patch test study of 90 patients with tattoo reactions: negative outcome of allergy patch test to baseline batteries and culprit inks suggests allergen(s) are generated in the skin through haptenization. Contact Dermat. 2014;71(5):255–63.Google Scholar
  91. 91.
    La Placa M, Passarini B. Subacute cutaneous lupus erythematosus after a tattoo. Clin Exp Dermatol. 2009;34(5):632–3.PubMedCrossRefGoogle Scholar
  92. 92.
    Kobner H. Aetiologie Ppsoriasis. Vjschr Dermatol. 1876;3:559.Google Scholar
  93. 93.
    Weiss G, Shemer A, Trau H. The Koebner phenomenon: review of the literature. J Eur Acad Dermatol Venereol JEADV. 2002;16(3):241–8.CrossRefGoogle Scholar
  94. 94.
    Litvinov IV, Sasseville D. Pyoderma gangrenosum triggered by red tattoo dye. CMAJ. 2014;186(12):935.Google Scholar
  95. 95.
    Jacobson S, Martin DB, Deng A, Cooper JZ. Pyoderma gangrenosum following tattoo placement in a patient with acute myelogenous leukemia. J Dermatol Treat. 2008;19(1):58–60.CrossRefGoogle Scholar
  96. 96.
    Arun B, Jamieson L, Mendonca C. An unusual presentation of lichen sclerosus et atrophicus in a tattoo. Clin Exp Dermatol. 2010;35(4):441.PubMedCrossRefGoogle Scholar
  97. 97.
    Kluger N, Koljonen V. Tattoos, inks, and cancer. Lancet Oncol. 2012;13(4):e161–8.PubMedCrossRefGoogle Scholar
  98. 98.
    Kluger N, Phan A, Debarbieux S, Balme B, Thomas L. Skin cancers arising in tattoos: coincidental or not? Dermatol Basel Switz. 2008;217(3):219–21.CrossRefGoogle Scholar
  99. 99.
    Cui Y, Spann AP, Couch LH, Gopee NV, Evans FE, Churchwell MI, Williams LD, Doerge DR, Howard PC. Photodecomposition of Pigment Yellow 74, a pigment used in tattoo inks. Photochem Photobiol. 2004;80(2):175–84.PubMedCrossRefGoogle Scholar
  100. 100.
    Balfour E, Olhoffer I, Leffell D, Handerson T. Massive pseudoepitheliomatous hyperplasia: an unusual reaction to a tattoo. Am J Dermatopathol. 2003;25(4):338–40.PubMedCrossRefGoogle Scholar
  101. 101.
    Kluger N, Durand L, Minier-Thoumin C, Plantier F, Cotten H, Berteloot E, Blatière V, Dereure O. Pseudoepitheliomatous epidermal hyperplasia in tattoos: report of three cases. Am J Clin Dermatol. 2008;9(5):337–40.PubMedCrossRefGoogle Scholar
  102. 102.
    Cui W, McGregor DH, Stark SP, Ulusarac O, Mathur SC. Pseudoepitheliomatous hyperplasia - an unusual reaction following tattoo: report of a case and review of the literature. Int J Dermatol. 2007;46(7):743–5.PubMedCrossRefGoogle Scholar
  103. 103.
    de Roeck A, Joujoux JM, Fournier F, Dandurand M, Meunier L, Stoebner PE. Florid pseudoepitheliomatous hyperplasia related to tattoo: a case report. Int Wound J. 2013;10(5):539–41.PubMedCrossRefGoogle Scholar
  104. 104.
    Zayour M, Lazova R. Pseudoepitheliomatous hyperplasia: a review. Am J Dermatopathol. 2011;33(2):112–122. (quiz 123–126).Google Scholar
  105. 105.
    Kluger N, Minier-Thoumin C, Plantier F. Keratoacanthoma occurring within the red dye of a tattoo. J Cutan Pathol. 2008;35(5):504–7.PubMedCrossRefGoogle Scholar
  106. 106.
    Fraga GR, Prossick TA. Tattoo-associated keratoacanthomas: a series of 8 patients with 11 keratoacanthomas. J Cutan Pathol. 2010;37(1):85–90.PubMedCrossRefGoogle Scholar
  107. 107.
    Kluger N, Koljonen V. The surgeon, the tattoo and the black lymph node. J Plast Reconstr Aesthet Surg JPRAS. 2013;66(4):561–2.CrossRefGoogle Scholar
  108. 108.
    Kluger N, Cohen-Valensi R, Nezri M. Black lymph nodes—and a colourful skin. Lancet. 2008;371(9619):1214.PubMedCrossRefGoogle Scholar
  109. 109.
    Yang AS, Creagh TA. Black sentinel lymph node and ‘scary stickers’. J Plast Reconstr Aesthet Surg. 2013;66(4):558–60.PubMedCrossRefGoogle Scholar
  110. 110.
    Manganoni AM, Sereni E, Pata G, Ungari M, Pavoni L, Farisoglio C, Calzavara-Pinton PG, Farfaglia R. Pigmentation of axillary sentinel nodes from extensive skin tattoo mimics metastatic melanoma: case report. Int J Dermatol. 2014;53(6):773–6.PubMedCrossRefGoogle Scholar
  111. 111.
    Gall N, Bröcker E-B, Becker JC. Particularities in managing melanoma patients with tattoos: case report and review of the literature. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2007;5(12):1120–1.CrossRefGoogle Scholar
  112. 112.
    Kreidstein ML, Giguere D, Freiberg A. MRI interaction with tattoo pigments: case report, pathophysiology, and management. Plast Reconstr Surg. 1997;99(6):1717–20.PubMedCrossRefGoogle Scholar
  113. 113.
    Tope WD, Shellock FG. Magnetic resonance imaging and permanent cosmetics (tattoos): survey of complications and adverse events. J Magn Reson Imaging JMRI. 2002;15(2):180–4.CrossRefGoogle Scholar
  114. 114.
    Vahlensieck M. Tattoo-related cutaneous inflammation (burn grade I) in a mid-field MR scanner. Eur Radiol. 2000;10(1):197.PubMedCrossRefGoogle Scholar
  115. 115.
    Ortiz AE, Avram MM. Redistribution of ink after laser tattoo removal. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2012;38(10):1730–1.Google Scholar
  116. 116.
    Molenda MA, Gehris RP, Jukic DM, Obagi S. Blue foot: an unusual complication of tattoo and successful treatment with a QS-Nd:YAG laser. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2008;34(7):947–9.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  1. 1.Division of DermatologyUniversity of WashingtonSeattleUSA

Personalised recommendations